nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Risedronate—PTGS2—colon cancer	0.0101	0.529	CrCbGaD
Pamidronate—Clodronate—PTGS2—colon cancer	0.00905	0.471	CrCbGaD
Pamidronate—FDPS—smooth muscle tissue—colon cancer	0.00827	0.166	CbGeAlD
Pamidronate—FDPS—renal system—colon cancer	0.00796	0.16	CbGeAlD
Pamidronate—FDPS—lymphoid tissue—colon cancer	0.00661	0.133	CbGeAlD
Pamidronate—FDPS—digestive system—colon cancer	0.00653	0.131	CbGeAlD
Pamidronate—FDPS—bone marrow—colon cancer	0.00602	0.121	CbGeAlD
Pamidronate—FDPS—vagina—colon cancer	0.00577	0.116	CbGeAlD
Pamidronate—FDPS—liver—colon cancer	0.00487	0.0978	CbGeAlD
Pamidronate—FDPS—lymph node—colon cancer	0.00373	0.075	CbGeAlD
Pamidronate—Syncope—Irinotecan—colon cancer	0.00239	0.00257	CcSEcCtD
Pamidronate—Renal failure acute—Methotrexate—colon cancer	0.00239	0.00257	CcSEcCtD
Pamidronate—Leukopenia—Irinotecan—colon cancer	0.00239	0.00256	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Capecitabine—colon cancer	0.00238	0.00256	CcSEcCtD
Pamidronate—Convulsion—Vincristine—colon cancer	0.00237	0.00255	CcSEcCtD
Pamidronate—Hypertension—Vincristine—colon cancer	0.00236	0.00254	CcSEcCtD
Pamidronate—Anaemia—Fluorouracil—colon cancer	0.00236	0.00254	CcSEcCtD
Pamidronate—Loss of consciousness—Irinotecan—colon cancer	0.00234	0.00252	CcSEcCtD
Pamidronate—Myalgia—Vincristine—colon cancer	0.00233	0.0025	CcSEcCtD
Pamidronate—Cough—Irinotecan—colon cancer	0.00233	0.0025	CcSEcCtD
Pamidronate—Hypertension—Irinotecan—colon cancer	0.0023	0.00247	CcSEcCtD
Pamidronate—Pneumonia—Capecitabine—colon cancer	0.0023	0.00247	CcSEcCtD
Pamidronate—Leukopenia—Fluorouracil—colon cancer	0.00229	0.00246	CcSEcCtD
Pamidronate—Infestation NOS—Capecitabine—colon cancer	0.00228	0.00245	CcSEcCtD
Pamidronate—Infestation—Capecitabine—colon cancer	0.00228	0.00245	CcSEcCtD
Pamidronate—Anaphylactoid reaction—Methotrexate—colon cancer	0.00228	0.00245	CcSEcCtD
Pamidronate—Lethargy—Methotrexate—colon cancer	0.00225	0.00242	CcSEcCtD
Pamidronate—Renal failure—Capecitabine—colon cancer	0.00225	0.00241	CcSEcCtD
Pamidronate—Discomfort—Irinotecan—colon cancer	0.00224	0.00241	CcSEcCtD
Pamidronate—Oedema—Vincristine—colon cancer	0.00224	0.0024	CcSEcCtD
Pamidronate—Anaphylactic shock—Vincristine—colon cancer	0.00224	0.0024	CcSEcCtD
Pamidronate—Stomatitis—Capecitabine—colon cancer	0.00223	0.00239	CcSEcCtD
Pamidronate—Infection—Vincristine—colon cancer	0.00222	0.00239	CcSEcCtD
Pamidronate—Urinary tract infection—Capecitabine—colon cancer	0.00222	0.00238	CcSEcCtD
Pamidronate—Conjunctivitis—Capecitabine—colon cancer	0.00222	0.00238	CcSEcCtD
Pamidronate—Convulsion—Fluorouracil—colon cancer	0.00221	0.00238	CcSEcCtD
Pamidronate—Osteoarthritis—Methotrexate—colon cancer	0.00221	0.00237	CcSEcCtD
Pamidronate—Confusional state—Irinotecan—colon cancer	0.00219	0.00236	CcSEcCtD
Pamidronate—Nervous system disorder—Vincristine—colon cancer	0.00219	0.00235	CcSEcCtD
Pamidronate—Thrombocytopenia—Vincristine—colon cancer	0.00219	0.00235	CcSEcCtD
Pamidronate—Haematuria—Capecitabine—colon cancer	0.00218	0.00234	CcSEcCtD
Pamidronate—Oedema—Irinotecan—colon cancer	0.00218	0.00234	CcSEcCtD
Pamidronate—Anaphylactic shock—Irinotecan—colon cancer	0.00218	0.00234	CcSEcCtD
Pamidronate—Myalgia—Fluorouracil—colon cancer	0.00217	0.00234	CcSEcCtD
Pamidronate—Infection—Irinotecan—colon cancer	0.00216	0.00232	CcSEcCtD
Pamidronate—Hyperhidrosis—Vincristine—colon cancer	0.00216	0.00232	CcSEcCtD
Pamidronate—Discomfort—Fluorouracil—colon cancer	0.00215	0.00231	CcSEcCtD
Pamidronate—Shock—Irinotecan—colon cancer	0.00214	0.0023	CcSEcCtD
Pamidronate—Nervous system disorder—Irinotecan—colon cancer	0.00213	0.00229	CcSEcCtD
Pamidronate—Agranulocytosis—Capecitabine—colon cancer	0.00213	0.00229	CcSEcCtD
Pamidronate—Thrombocytopenia—Irinotecan—colon cancer	0.00213	0.00229	CcSEcCtD
Pamidronate—Anorexia—Vincristine—colon cancer	0.00213	0.00229	CcSEcCtD
Pamidronate—Hyperhidrosis—Irinotecan—colon cancer	0.0021	0.00226	CcSEcCtD
Pamidronate—Confusional state—Fluorouracil—colon cancer	0.0021	0.00226	CcSEcCtD
Pamidronate—Hypotension—Vincristine—colon cancer	0.00209	0.00224	CcSEcCtD
Pamidronate—Anaphylactic shock—Fluorouracil—colon cancer	0.00208	0.00224	CcSEcCtD
Pamidronate—Oedema—Fluorouracil—colon cancer	0.00208	0.00224	CcSEcCtD
Pamidronate—Anorexia—Irinotecan—colon cancer	0.00207	0.00223	CcSEcCtD
Pamidronate—Infection—Fluorouracil—colon cancer	0.00207	0.00222	CcSEcCtD
Pamidronate—Haemoglobin—Capecitabine—colon cancer	0.00206	0.00221	CcSEcCtD
Pamidronate—Rhinitis—Capecitabine—colon cancer	0.00206	0.00221	CcSEcCtD
Pamidronate—Haemorrhage—Capecitabine—colon cancer	0.00205	0.0022	CcSEcCtD
Pamidronate—Nervous system disorder—Fluorouracil—colon cancer	0.00204	0.0022	CcSEcCtD
Pamidronate—Thrombocytopenia—Fluorouracil—colon cancer	0.00204	0.00219	CcSEcCtD
Pamidronate—Liver function test abnormal—Methotrexate—colon cancer	0.00204	0.00219	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Vincristine—colon cancer	0.00204	0.00219	CcSEcCtD
Pamidronate—Tachycardia—Fluorouracil—colon cancer	0.00203	0.00219	CcSEcCtD
Pamidronate—Hypotension—Irinotecan—colon cancer	0.00203	0.00218	CcSEcCtD
Pamidronate—Urinary tract disorder—Capecitabine—colon cancer	0.00203	0.00218	CcSEcCtD
Pamidronate—Insomnia—Vincristine—colon cancer	0.00202	0.00217	CcSEcCtD
Pamidronate—Connective tissue disorder—Capecitabine—colon cancer	0.00202	0.00216	CcSEcCtD
Pamidronate—Urethral disorder—Capecitabine—colon cancer	0.00201	0.00216	CcSEcCtD
Pamidronate—Paraesthesia—Vincristine—colon cancer	0.00201	0.00216	CcSEcCtD
Pamidronate—Anorexia—Fluorouracil—colon cancer	0.00199	0.00213	CcSEcCtD
Pamidronate—Insomnia—Irinotecan—colon cancer	0.00197	0.00211	CcSEcCtD
Pamidronate—Paraesthesia—Irinotecan—colon cancer	0.00195	0.0021	CcSEcCtD
Pamidronate—Hypotension—Fluorouracil—colon cancer	0.00195	0.00209	CcSEcCtD
Pamidronate—Decreased appetite—Vincristine—colon cancer	0.00194	0.00209	CcSEcCtD
Pamidronate—Dyspnoea—Irinotecan—colon cancer	0.00194	0.00208	CcSEcCtD
Pamidronate—Somnolence—Irinotecan—colon cancer	0.00194	0.00208	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Vincristine—colon cancer	0.00193	0.00207	CcSEcCtD
Pamidronate—Fatigue—Vincristine—colon cancer	0.00193	0.00207	CcSEcCtD
Pamidronate—Eye disorder—Capecitabine—colon cancer	0.00192	0.00206	CcSEcCtD
Pamidronate—Dyspepsia—Irinotecan—colon cancer	0.00192	0.00206	CcSEcCtD
Pamidronate—Pain—Vincristine—colon cancer	0.00191	0.00205	CcSEcCtD
Pamidronate—Constipation—Vincristine—colon cancer	0.00191	0.00205	CcSEcCtD
Pamidronate—Flushing—Capecitabine—colon cancer	0.0019	0.00204	CcSEcCtD
Pamidronate—Cardiac disorder—Capecitabine—colon cancer	0.0019	0.00204	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0019	0.00204	CcSEcCtD
Pamidronate—Decreased appetite—Irinotecan—colon cancer	0.00189	0.00203	CcSEcCtD
Pamidronate—Insomnia—Fluorouracil—colon cancer	0.00189	0.00203	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Irinotecan—colon cancer	0.00188	0.00202	CcSEcCtD
Pamidronate—Fatigue—Irinotecan—colon cancer	0.00188	0.00202	CcSEcCtD
Pamidronate—Paraesthesia—Fluorouracil—colon cancer	0.00187	0.00201	CcSEcCtD
Pamidronate—Pain—Irinotecan—colon cancer	0.00186	0.002	CcSEcCtD
Pamidronate—Constipation—Irinotecan—colon cancer	0.00186	0.002	CcSEcCtD
Pamidronate—Angiopathy—Capecitabine—colon cancer	0.00186	0.002	CcSEcCtD
Pamidronate—Dyspnoea—Fluorouracil—colon cancer	0.00186	0.002	CcSEcCtD
Pamidronate—Somnolence—Fluorouracil—colon cancer	0.00185	0.00199	CcSEcCtD
Pamidronate—Immune system disorder—Capecitabine—colon cancer	0.00185	0.00199	CcSEcCtD
Pamidronate—Mediastinal disorder—Capecitabine—colon cancer	0.00185	0.00199	CcSEcCtD
Pamidronate—Chills—Capecitabine—colon cancer	0.00184	0.00198	CcSEcCtD
Pamidronate—Dyspepsia—Fluorouracil—colon cancer	0.00184	0.00197	CcSEcCtD
Pamidronate—Gastrointestinal pain—Vincristine—colon cancer	0.00183	0.00196	CcSEcCtD
Pamidronate—Decreased appetite—Fluorouracil—colon cancer	0.00181	0.00195	CcSEcCtD
Pamidronate—Alopecia—Capecitabine—colon cancer	0.00181	0.00195	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.0018	0.00193	CcSEcCtD
Pamidronate—Feeling abnormal—Irinotecan—colon cancer	0.00179	0.00193	CcSEcCtD
Pamidronate—Erythema—Capecitabine—colon cancer	0.00179	0.00192	CcSEcCtD
Pamidronate—Malnutrition—Capecitabine—colon cancer	0.00179	0.00192	CcSEcCtD
Pamidronate—Neutropenia—Methotrexate—colon cancer	0.00178	0.00192	CcSEcCtD
Pamidronate—Pain—Fluorouracil—colon cancer	0.00178	0.00191	CcSEcCtD
Pamidronate—Gastrointestinal pain—Irinotecan—colon cancer	0.00178	0.00191	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Methotrexate—colon cancer	0.00177	0.0019	CcSEcCtD
Pamidronate—Abdominal pain—Vincristine—colon cancer	0.00177	0.0019	CcSEcCtD
Pamidronate—Body temperature increased—Vincristine—colon cancer	0.00177	0.0019	CcSEcCtD
Pamidronate—Dysgeusia—Capecitabine—colon cancer	0.00175	0.00188	CcSEcCtD
Pamidronate—Back pain—Capecitabine—colon cancer	0.00173	0.00185	CcSEcCtD
Pamidronate—Abdominal pain—Irinotecan—colon cancer	0.00172	0.00185	CcSEcCtD
Pamidronate—Body temperature increased—Irinotecan—colon cancer	0.00172	0.00185	CcSEcCtD
Pamidronate—Feeling abnormal—Fluorouracil—colon cancer	0.00172	0.00185	CcSEcCtD
Pamidronate—Muscle spasms—Capecitabine—colon cancer	0.00172	0.00184	CcSEcCtD
Pamidronate—Pneumonia—Methotrexate—colon cancer	0.00171	0.00184	CcSEcCtD
Pamidronate—Infestation NOS—Methotrexate—colon cancer	0.0017	0.00183	CcSEcCtD
Pamidronate—Infestation—Methotrexate—colon cancer	0.0017	0.00183	CcSEcCtD
Pamidronate—Renal failure—Methotrexate—colon cancer	0.00167	0.0018	CcSEcCtD
Pamidronate—Stomatitis—Methotrexate—colon cancer	0.00166	0.00178	CcSEcCtD
Pamidronate—Ill-defined disorder—Capecitabine—colon cancer	0.00166	0.00178	CcSEcCtD
Pamidronate—Conjunctivitis—Methotrexate—colon cancer	0.00165	0.00178	CcSEcCtD
Pamidronate—Anaemia—Capecitabine—colon cancer	0.00165	0.00177	CcSEcCtD
Pamidronate—Body temperature increased—Fluorouracil—colon cancer	0.00165	0.00177	CcSEcCtD
Pamidronate—Hypersensitivity—Vincristine—colon cancer	0.00165	0.00177	CcSEcCtD
Pamidronate—Haematuria—Methotrexate—colon cancer	0.00162	0.00174	CcSEcCtD
Pamidronate—Malaise—Capecitabine—colon cancer	0.00161	0.00173	CcSEcCtD
Pamidronate—Hypersensitivity—Irinotecan—colon cancer	0.0016	0.00172	CcSEcCtD
Pamidronate—Asthenia—Vincristine—colon cancer	0.0016	0.00172	CcSEcCtD
Pamidronate—Syncope—Capecitabine—colon cancer	0.0016	0.00172	CcSEcCtD
Pamidronate—Leukopenia—Capecitabine—colon cancer	0.0016	0.00172	CcSEcCtD
Pamidronate—Agranulocytosis—Methotrexate—colon cancer	0.00159	0.0017	CcSEcCtD
Pamidronate—Loss of consciousness—Capecitabine—colon cancer	0.00157	0.00169	CcSEcCtD
Pamidronate—Asthenia—Irinotecan—colon cancer	0.00156	0.00168	CcSEcCtD
Pamidronate—Cough—Capecitabine—colon cancer	0.00156	0.00167	CcSEcCtD
Pamidronate—Hypertension—Capecitabine—colon cancer	0.00154	0.00166	CcSEcCtD
Pamidronate—Hypersensitivity—Fluorouracil—colon cancer	0.00154	0.00165	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—colon cancer	0.00153	0.00165	CcSEcCtD
Pamidronate—Diarrhoea—Vincristine—colon cancer	0.00153	0.00164	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—colon cancer	0.00153	0.00164	CcSEcCtD
Pamidronate—Arthralgia—Capecitabine—colon cancer	0.00152	0.00163	CcSEcCtD
Pamidronate—Myalgia—Capecitabine—colon cancer	0.00152	0.00163	CcSEcCtD
Pamidronate—Anxiety—Capecitabine—colon cancer	0.00151	0.00163	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—colon cancer	0.00151	0.00162	CcSEcCtD
Pamidronate—Discomfort—Capecitabine—colon cancer	0.0015	0.00161	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—colon cancer	0.0015	0.00161	CcSEcCtD
Pamidronate—Diarrhoea—Irinotecan—colon cancer	0.00149	0.0016	CcSEcCtD
Pamidronate—Dizziness—Vincristine—colon cancer	0.00148	0.00159	CcSEcCtD
Pamidronate—Pruritus—Fluorouracil—colon cancer	0.00148	0.00158	CcSEcCtD
Pamidronate—Confusional state—Capecitabine—colon cancer	0.00147	0.00158	CcSEcCtD
Pamidronate—Oedema—Capecitabine—colon cancer	0.00146	0.00156	CcSEcCtD
Pamidronate—Infection—Capecitabine—colon cancer	0.00145	0.00155	CcSEcCtD
Pamidronate—Dizziness—Irinotecan—colon cancer	0.00144	0.00155	CcSEcCtD
Pamidronate—Shock—Capecitabine—colon cancer	0.00143	0.00154	CcSEcCtD
Pamidronate—Nervous system disorder—Capecitabine—colon cancer	0.00143	0.00153	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—colon cancer	0.00143	0.00153	CcSEcCtD
Pamidronate—Diarrhoea—Fluorouracil—colon cancer	0.00143	0.00153	CcSEcCtD
Pamidronate—Thrombocytopenia—Capecitabine—colon cancer	0.00143	0.00153	CcSEcCtD
Pamidronate—Tachycardia—Capecitabine—colon cancer	0.00142	0.00153	CcSEcCtD
Pamidronate—Vomiting—Vincristine—colon cancer	0.00142	0.00153	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—colon cancer	0.00142	0.00152	CcSEcCtD
Pamidronate—Rash—Vincristine—colon cancer	0.00141	0.00151	CcSEcCtD
Pamidronate—Hyperhidrosis—Capecitabine—colon cancer	0.00141	0.00151	CcSEcCtD
Pamidronate—Dermatitis—Vincristine—colon cancer	0.00141	0.00151	CcSEcCtD
Pamidronate—Headache—Vincristine—colon cancer	0.0014	0.0015	CcSEcCtD
Pamidronate—Anorexia—Capecitabine—colon cancer	0.00139	0.00149	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—colon cancer	0.00139	0.00149	CcSEcCtD
Pamidronate—Vomiting—Irinotecan—colon cancer	0.00138	0.00149	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—colon cancer	0.00138	0.00148	CcSEcCtD
Pamidronate—Dizziness—Fluorouracil—colon cancer	0.00138	0.00148	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—colon cancer	0.00138	0.00148	CcSEcCtD
Pamidronate—Rash—Irinotecan—colon cancer	0.00137	0.00147	CcSEcCtD
Pamidronate—Dermatitis—Irinotecan—colon cancer	0.00137	0.00147	CcSEcCtD
Pamidronate—Chills—Methotrexate—colon cancer	0.00137	0.00147	CcSEcCtD
Pamidronate—Headache—Irinotecan—colon cancer	0.00136	0.00146	CcSEcCtD
Pamidronate—Hypotension—Capecitabine—colon cancer	0.00136	0.00146	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—colon cancer	0.00135	0.00145	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—colon cancer	0.00133	0.00143	CcSEcCtD
Pamidronate—Erythema—Methotrexate—colon cancer	0.00133	0.00143	CcSEcCtD
Pamidronate—Nausea—Vincristine—colon cancer	0.00133	0.00143	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00133	0.00143	CcSEcCtD
Pamidronate—Vomiting—Fluorouracil—colon cancer	0.00133	0.00142	CcSEcCtD
Pamidronate—Insomnia—Capecitabine—colon cancer	0.00132	0.00142	CcSEcCtD
Pamidronate—Rash—Fluorouracil—colon cancer	0.00131	0.00141	CcSEcCtD
Pamidronate—Dermatitis—Fluorouracil—colon cancer	0.00131	0.00141	CcSEcCtD
Pamidronate—Paraesthesia—Capecitabine—colon cancer	0.00131	0.00141	CcSEcCtD
Pamidronate—Headache—Fluorouracil—colon cancer	0.00131	0.0014	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—colon cancer	0.0013	0.0014	CcSEcCtD
Pamidronate—Dyspnoea—Capecitabine—colon cancer	0.0013	0.0014	CcSEcCtD
Pamidronate—Nausea—Irinotecan—colon cancer	0.00129	0.00139	CcSEcCtD
Pamidronate—Back pain—Methotrexate—colon cancer	0.00129	0.00138	CcSEcCtD
Pamidronate—Dyspepsia—Capecitabine—colon cancer	0.00128	0.00138	CcSEcCtD
Pamidronate—Decreased appetite—Capecitabine—colon cancer	0.00127	0.00136	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Capecitabine—colon cancer	0.00126	0.00135	CcSEcCtD
Pamidronate—Fatigue—Capecitabine—colon cancer	0.00126	0.00135	CcSEcCtD
Pamidronate—Constipation—Capecitabine—colon cancer	0.00125	0.00134	CcSEcCtD
Pamidronate—Pain—Capecitabine—colon cancer	0.00125	0.00134	CcSEcCtD
Pamidronate—Nausea—Fluorouracil—colon cancer	0.00124	0.00133	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—colon cancer	0.00123	0.00132	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—colon cancer	0.00123	0.00132	CcSEcCtD
Pamidronate—Feeling abnormal—Capecitabine—colon cancer	0.0012	0.00129	CcSEcCtD
Pamidronate—Malaise—Methotrexate—colon cancer	0.0012	0.00129	CcSEcCtD
Pamidronate—Gastrointestinal pain—Capecitabine—colon cancer	0.00119	0.00128	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—colon cancer	0.00119	0.00128	CcSEcCtD
Pamidronate—Cough—Methotrexate—colon cancer	0.00116	0.00125	CcSEcCtD
Pamidronate—Abdominal pain—Capecitabine—colon cancer	0.00115	0.00124	CcSEcCtD
Pamidronate—Body temperature increased—Capecitabine—colon cancer	0.00115	0.00124	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—colon cancer	0.00115	0.00124	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—colon cancer	0.00113	0.00122	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—colon cancer	0.00113	0.00122	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—colon cancer	0.00112	0.0012	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—colon cancer	0.00109	0.00117	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—colon cancer	0.00108	0.00116	CcSEcCtD
Pamidronate—Infection—Methotrexate—colon cancer	0.00108	0.00116	CcSEcCtD
Pamidronate—Hypersensitivity—Capecitabine—colon cancer	0.00107	0.00115	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—colon cancer	0.00106	0.00114	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—colon cancer	0.00106	0.00114	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—colon cancer	0.00105	0.00113	CcSEcCtD
Pamidronate—Asthenia—Capecitabine—colon cancer	0.00105	0.00112	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—colon cancer	0.00103	0.00111	CcSEcCtD
Pamidronate—Pruritus—Capecitabine—colon cancer	0.00103	0.00111	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—colon cancer	0.00101	0.00109	CcSEcCtD
Pamidronate—Diarrhoea—Capecitabine—colon cancer	0.000997	0.00107	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000988	0.00106	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—colon cancer	0.000981	0.00105	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—colon cancer	0.000974	0.00105	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—colon cancer	0.000967	0.00104	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—colon cancer	0.000964	0.00104	CcSEcCtD
Pamidronate—Dizziness—Capecitabine—colon cancer	0.000963	0.00103	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—colon cancer	0.000955	0.00103	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—colon cancer	0.000943	0.00101	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—colon cancer	0.000936	0.00101	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—colon cancer	0.000935	0.001	CcSEcCtD
Pamidronate—Pain—Methotrexate—colon cancer	0.000927	0.000996	CcSEcCtD
Pamidronate—Vomiting—Capecitabine—colon cancer	0.000926	0.000995	CcSEcCtD
Pamidronate—Rash—Capecitabine—colon cancer	0.000919	0.000987	CcSEcCtD
Pamidronate—Dermatitis—Capecitabine—colon cancer	0.000918	0.000986	CcSEcCtD
Pamidronate—Headache—Capecitabine—colon cancer	0.000913	0.00098	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—colon cancer	0.000894	0.00096	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—colon cancer	0.000887	0.000953	CcSEcCtD
Pamidronate—Nausea—Capecitabine—colon cancer	0.000865	0.000929	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—colon cancer	0.000857	0.000921	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—colon cancer	0.000857	0.000921	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—colon cancer	0.000799	0.000858	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—colon cancer	0.000778	0.000836	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—colon cancer	0.000767	0.000824	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—colon cancer	0.000742	0.000797	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—colon cancer	0.000717	0.00077	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—colon cancer	0.00069	0.000741	CcSEcCtD
Pamidronate—Rash—Methotrexate—colon cancer	0.000684	0.000734	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—colon cancer	0.000683	0.000734	CcSEcCtD
Pamidronate—Headache—Methotrexate—colon cancer	0.000679	0.00073	CcSEcCtD
Pamidronate—Nausea—Methotrexate—colon cancer	0.000644	0.000692	CcSEcCtD
